Author/Authors :
Torkashvand, Fatemeh Medical Biotechnology Department - Biotechnology Research Center - Pasteur Institute of Iran, Tehran, Iran , Mahboudi, Fereidoun Medical Biotechnology Department - Biotechnology Research Center - Pasteur Institute of Iran, Tehran, Iran , Vossoughi, Manouchehr Department of Chemical and Petroleum Engineering - Biochemical and Bioenvironmental Research Center Sharif University of Technology, Tehran, Iran , Fatemi, Elnaz Medical Biotechnology Department - Biotechnology Research Center - Pasteur Institute of Iran, Tehran, Iran , Moosavi Basri, Masoud Medical Biotechnology Department - Biotechnology Research Center - Pasteur Institute of Iran, Tehran, Iran , Heydari, Amir Department of Chemical Engineering - University of Mohaghegh Ardabili, Ardabil, Iran , Vaziri, Behrouz Medical Biotechnology Department - Biotechnology Research Center - Pasteur Institute of Iran, Tehran, Iran
Abstract :
Background: Chinese hamster ovary (CHO) cell line is considered as the most common cell line in the
biopharmaceutical industry because of its capability in performing efficient post-translational modifications and
producing the recombinant proteins, which are similar to natural human proteins. The optimization of the
upstream process via different feed strategies has a great impact on the target molecule expression and yield.
Methods: To determine and understand the molecular events beneath the feed effects on the CHO cell, a labelfree
quantitative proteomic analysis was applied. The proteome changes followed by the addition of a designed
amino acid feed to the monoclonal antibody producing CHO cell line culture medium were investigated. Results:
The glutathione synthesis, the negative regulation of the programmed cell death, proteasomal catabolic process,
and the endosomal transport pathway were up-regulated in the group fed with a designed amino acid feed
compared to the control group. Conclusion: Our findings could be helpful to identify new targets for metabolic
engineering.
Keywords :
Proteomics , Monoclonal antibodies , Glutathione , CHO cells